ASPIRA WOMEN'S HEALTH INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01Regulation FD Disclosure.

On January 5, 2022, Aspira Women's Health Inc. issued a press release announcing certain operational metrics for the fourth quarter of 2021 and an update regarding its OvaWatch and EndoCheck programs. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K filing.

Item 9.01Financial Statements and Exhibits.

 (d)     Exhibits



Exhibit No.   Description
     99.1       Press Release issued by Aspira Women's Health Inc. on January 5, 2022

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses